Ssme nexus
Author: N | 2025-04-25
I recently tried to install SSME from Nexus and was unable to; had nothing to do with Nexus as the file downloaded properly. It unzipped to the two files which the installation
SSME - Skyrim Startup Memory Editor at Skyrim Nexus - Nexus
Hello everybody,I downloaded skyrim long time ago, at the beginning I Played without mod and it was working fine without crashing. Then I added mod and it was fine, then I modified the skyrim.ini and the preference file in order to be able to see the grace and NPC much more further, and at this moment a lot of crash to desktop occurred, and now I can't play without crash to desktop everytime I try to load after having quick save.With some research I found that it was a memory problem, so I download SSME as recommend in many forums. I extract SSME files (a dll file and SSME.ini) in my skyrim folder, not in data bit with the skse launcher (Last version). On SSME page I saw that if SSME was load by skyrim it will create a ssme.log, and this is my problem, I have no ssme.log created.So what do I have to do for ssme to be load by skyrim ??Please help meThanksSorry for my English I recently tried to install SSME from Nexus and was unable to; had nothing to do with Nexus as the file downloaded properly. It unzipped to the two files which the installation Options are designed to focus on symptoms and coping strategies instead of directly targeting cognitive functioning. These therapeutic shortfalls are especially concerning for younger populations who are potentially facing a lifetime of managing these conditions.Akili’s First-of-Its-Kind, Clinically Validated TherapeuticBy harnessing advances in cognitive neuroscience and consumer technology, Akili is changing the neuropsychiatric treatment paradigm. Akili’s patented and clinically validated technology platform represents a new category of software-based medicine: advanced and proprietary digital therapeutics that are designed to directly target neural physiology to better serve the needs of patients and their families.Akili’s core therapeutic engine, the Selective Stimulus Management Engine (SSME™), is specifically designed to target and activate neural systems involved in attentional control. This core platform has the potential to be applied across a diverse set of indications within psychiatry and neurology. Backed by robust clinical research, Akili’s treatments are delivered to patients through engaging interactive mobile games, personalized to each individual and built to feel like high-end entertainment products.The SSME™ technology has already demonstrated proof-of-concept in controlled trials targeting attention and cognitive dysfunction in ADHD, ASD, MS, and MDD. Built on the SSME™ technology, Akili developed EndeavorRx®, the first-ever FDA-cleared prescription video game and the first-ever FDA-cleared commercial product indicated to improve attention function in children between the ages of 8 to 12 years with primarily inattentive or combined-type ADHD (see full indication below). Key Investment Highlights:Patented and clinically validated technology platform. Developed with the collaboration of cognitive neuroscientists and mobile game developers, Akili’s proprietary technology is designed to target key neural systems underlying specific cognitive functions through adaptable, personalized closed-loop algorithms. The technology is clinically validated, using recognized endpoints, and delivered through smartphones or other mobile devices.First-and-only FDA-cleared video game-based digital therapeutic. Anticipated to launch in the second half of 2022, EndeavorRx® is the first and only prescription video game treatment with FDA clearance and a CE mark (designating it has met European health, safety, performance, and environmental requirements) in pediatric ADHD. EndeavorRx® has been validated through multiple clinical trials, including large randomized, controlled trials demonstrating improved patient outcomes.Large and growing market opportunity. Tens of millions of people worldwide live with cognitive health issues, and many are actively searching for better solutions. With EndeavorRx®, Akili is initially targeting the approximately $10 billion U.S. ADHD market. EndeavorRx® will first launch for the FDA-cleared 8 to 12-year-old pediatric population. Akili is also seeking to expand into other U.S. ADHD populations,Comments
Hello everybody,I downloaded skyrim long time ago, at the beginning I Played without mod and it was working fine without crashing. Then I added mod and it was fine, then I modified the skyrim.ini and the preference file in order to be able to see the grace and NPC much more further, and at this moment a lot of crash to desktop occurred, and now I can't play without crash to desktop everytime I try to load after having quick save.With some research I found that it was a memory problem, so I download SSME as recommend in many forums. I extract SSME files (a dll file and SSME.ini) in my skyrim folder, not in data bit with the skse launcher (Last version). On SSME page I saw that if SSME was load by skyrim it will create a ssme.log, and this is my problem, I have no ssme.log created.So what do I have to do for ssme to be load by skyrim ??Please help meThanksSorry for my English
2025-04-11Options are designed to focus on symptoms and coping strategies instead of directly targeting cognitive functioning. These therapeutic shortfalls are especially concerning for younger populations who are potentially facing a lifetime of managing these conditions.Akili’s First-of-Its-Kind, Clinically Validated TherapeuticBy harnessing advances in cognitive neuroscience and consumer technology, Akili is changing the neuropsychiatric treatment paradigm. Akili’s patented and clinically validated technology platform represents a new category of software-based medicine: advanced and proprietary digital therapeutics that are designed to directly target neural physiology to better serve the needs of patients and their families.Akili’s core therapeutic engine, the Selective Stimulus Management Engine (SSME™), is specifically designed to target and activate neural systems involved in attentional control. This core platform has the potential to be applied across a diverse set of indications within psychiatry and neurology. Backed by robust clinical research, Akili’s treatments are delivered to patients through engaging interactive mobile games, personalized to each individual and built to feel like high-end entertainment products.The SSME™ technology has already demonstrated proof-of-concept in controlled trials targeting attention and cognitive dysfunction in ADHD, ASD, MS, and MDD. Built on the SSME™ technology, Akili developed EndeavorRx®, the first-ever FDA-cleared prescription video game and the first-ever FDA-cleared commercial product indicated to improve attention function in children between the ages of 8 to 12 years with primarily inattentive or combined-type ADHD (see full indication below). Key Investment Highlights:Patented and clinically validated technology platform. Developed with the collaboration of cognitive neuroscientists and mobile game developers, Akili’s proprietary technology is designed to target key neural systems underlying specific cognitive functions through adaptable, personalized closed-loop algorithms. The technology is clinically validated, using recognized endpoints, and delivered through smartphones or other mobile devices.First-and-only FDA-cleared video game-based digital therapeutic. Anticipated to launch in the second half of 2022, EndeavorRx® is the first and only prescription video game treatment with FDA clearance and a CE mark (designating it has met European health, safety, performance, and environmental requirements) in pediatric ADHD. EndeavorRx® has been validated through multiple clinical trials, including large randomized, controlled trials demonstrating improved patient outcomes.Large and growing market opportunity. Tens of millions of people worldwide live with cognitive health issues, and many are actively searching for better solutions. With EndeavorRx®, Akili is initially targeting the approximately $10 billion U.S. ADHD market. EndeavorRx® will first launch for the FDA-cleared 8 to 12-year-old pediatric population. Akili is also seeking to expand into other U.S. ADHD populations,
2025-04-14As Ferram control surfaces.I do not recommend using this part, as it doesn't generate nearly as much drag as I'd like.Other changes:Textures and part modifications:complete part rework with model fixed all aroundheat shield glow emissive effectSRB separation motors fixedcustom ET texturesNew SRB texture variants for booster and nosecone, added lighter Filament-Wound booster variantCabin texture reworked, ejection seat panels for Enterprise and old Columbia, custom tile patterns around the side hatch, unique tiles on the forward RCS blockCargo bay and engine mount texture reworkedFictional Enterprise orbital version and MoonrakerTail texture reworked for Challenger and Columbia SILTS podNew elevon variant with original Columbia tile patternNew normal maps for all part variantsOMS pod variant without black tilesNew "empty cockpit" variant with only the IVA shell and no gauges, lighter on the FPS as I like to land IVA but have no use for the gaugesWaterfallnew effects for the SRBs, made a custom smoke-only Smokescreen config for the smoke columnrework of the Waterfall OMS and SSME configs with minor tweaksRO configshigher SRB decoupler force so that they will separate cleanly without the aft separation motors (broken)lower wheel braking forcethermal configs taken from the updated configs in the main RO release, bit higher tolerance on the nose cabinCustom aerodynamics moduleControl surfaces come pre-configured for my Shuttle Entry script
2025-03-29